Spire Wealth Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$30.4K 2493
2025
Q1
$30.4K Hold
4,000
﹤0.01% 1468
2024
Q4
$38.5K Hold
4,000
﹤0.01% 1387
2024
Q3
$23.6K Hold
4,000
﹤0.01% 1389
2024
Q2
$27.7K Hold
4,000
﹤0.01% 1316
2024
Q1
$30.8K Hold
4,000
﹤0.01% 1378
2023
Q4
$32.6K Hold
4,000
﹤0.01% 1347
2023
Q3
$29.2K Hold
4,000
﹤0.01% 1363
2023
Q2
$26.4K Hold
4,000
﹤0.01% 1466
2023
Q1
$13.6K Buy
+4,000
New +$15.5K ﹤0.01% 1750
2022
Q3
Sell
-4,000
Closed -$14K 2440
2022
Q2
$14K Hold
4,000
﹤0.01% 1801
2022
Q1
$19K Hold
4,000
﹤0.01% 1836
2021
Q4
$24K Sell
4,000
-454
-10% -$3.15K ﹤0.01% 2052
2021
Q3
$27K Hold
4,454
﹤0.01% 1731
2021
Q2
$56K Hold
4,454
﹤0.01% 1433
2021
Q1
$46K Buy
+4,454
New +$43K ﹤0.01% 1760

Other funds holding MDXG

Spire Wealth Management's MDXG Position: Q2 2025 in Review

Spire Wealth Management sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 4,000 shares — an estimated $30.4K sold.

Spire Wealth Management first reported a position in MDXG in Q1 2021 and held it in 15 quarters. The position peaked at $56K in Q2 2021. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

  • Spire Wealth Management reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
  • Spire Wealth Management sold 4,000 MiMedx Group shares in Q2 2025, an estimated $30.4K.
  • Spire Wealth Management first reported a position in MiMedx Group in Q1 2021 and held it in 15 quarters.
  • Spire Wealth Management's MiMedx Group position peaked at $56K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on Spire Wealth Management's 13F filing for Q2 2025, filed 4 Aug 2025.